Boehringer and Eli Lilly have moved closer to a heart failure indication for their SGLT2 inhibitor Jardiance, as the FDA starts a fast-track review of the drug in its first use beyond diabetes. The US ...

Novo Nordisk's Rybelsus has become the first oral GLP-1 agonist to pick up a regulatory approval for cardiovascular risk reduction, after getting a green light from the EMA's human medicine committee.

Since the procedures adopted in all these studies varied greatly it is conceivable that the diversity and the inconsistency of the results were partly due to the lack of a standardized procedure. The ...

Abstract: Existing Zero-Shot Learning (ZSL) approaches for sensor-based Human Activity Recognition (HAR) often rely on external semantic information—such as attribute annotations or textual ...

Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan, Molecular Imaging Center, National Institute of Radiological Sciences, Anagawa, Inage-ku, ...

Abstract: Cardiovascular disease (CVD) is a leading cause of global mortality, accounting for an estimated 17.9 million deaths annually. CVD is broadly defined as a group of medical conditions ...